The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo
Open accessAbstract
Significance: Converging lines of evidence suggest that increase in α-syn levels plays a central role in synucleinopathies pathogenesis. Therefore, lowering α-syn levels represents a viable therapeutic strategy for these disorders. Here, we describe a previously uncharacterized cellular mechanism controlling the selective autophagic degradation of α-syn. This effect is governed by PLK2 kinase activity, phosphorylation of α-syn, and PLK2/α-syn complex formation. In a rat model of Parkinson disease, PLK2 overexpression reduces α-syn levels and suppresses α-syn–induced toxicity and motor deficits. Collectively, our data support the neuroprotective role of PLK2 and suggest that modulating its activity is a viable therapeutic strategy for the treatment of Parkinson disease and related synucleinopathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylated α-Synuclein Is Ubiquitinated in α-Synucleinopathy Lesions
Hasegawa, M., Fujiwara, H., Nonaka, T., Wakabayashi, K., Takahashi, H., Lee, V. M.-Y., Trojanowski, J. Q., Mann, D., & Iwatsubo, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208046200 · Cited by 428
Hyperphosphorylation and insolubility of α‐synuclein in transgenic mouse oligodendrocytes
Kahle, P. J., Neumann, M., Ozmen, L., Müller, V., Jacobsen, H., Spooren, W., Fuss, B., Mallon, B., Macklin, W. B., Fujiwara, H., et al. (2002) · The EMBO Reports · doi:10.1093/embo-reports/kvf109 · Cited by 314
Cited by
α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies
Wong, Y. C., & Krainc, D. (2017) · Nature Medicine · doi:10.1038/nm.4269 · Cited by 897
Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease
Rocha, E. M., De Miranda, B., & Sanders, L. H. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.04.004 · Cited by 762
LRRK2 activation in idiopathic Parkinson’s disease
Di Maio, R., Hoffman, E. K., Rocha, E. M., Keeney, M. T., Sanders, L. H., De Miranda, B. R., Zharikov, A., Van Laar, A., Stepan, A. F., Lanz, T. A., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar5429 · Cited by 564
Dehay, B., Bourdenx, M., Gorry, P., Przedborski, S., Vila, M., Hunot, S., Singleton, A., Olanow, C. W., Merchant, K. M., Bezard, E., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00006-x · Cited by 529
Polo-like kinases: structural variations lead to multiple functions
Zitouni, S., Nabais, C., Jana, S. C., Guerrero, A., & Bettencourt-Dias, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3819 · Cited by 489
Metadata
- Authors
- Oueslati, A., Schneider, B. L., Aebischer, P., & Lashuel, H. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2013-08-27
- Volume
- 110
- Issue
- 41
- Pages
- E3945-54
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2167390229
- Cited by
- 203
- References
- 2
- FWCI
- 10.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo. https://app.cochat.ai/papers/10.1073/pnas.1309991110
- The paper
- Oueslati, A., Schneider, B. L., Aebischer, P., & Lashuel, H. A. (2013). Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1309991110
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.